214 related articles for article (PubMed ID: 31400949)
1. Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all.
Kasivisvanathan V; Takwoingi Y; Emberton M; Moore CM
Eur Urol; 2019 Nov; 76(5):e133-e134. PubMed ID: 31400949
[No Abstract] [Full Text] [Related]
2. Reply to Francesco Montorsi, Armando Stabile, Elio Mazzone, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13.
Reddy D; Ahmed HU
Eur Urol; 2022 Sep; 82(3):e74-e75. PubMed ID: 35690513
[No Abstract] [Full Text] [Related]
3. Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303.
Montorsi F; Gandaglia G; Briganti A
Eur Urol; 2019 Nov; 76(5):e132. PubMed ID: 31400947
[No Abstract] [Full Text] [Related]
4. Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2019;76:284-303: Threshold Indication for Magnetic Resonance Imaging-targeted Biopsy in the Detection of Prostate Cancer.
Kim JH; Jeong IG
Eur Urol; 2020 May; 77(5):e134-e135. PubMed ID: 31980314
[No Abstract] [Full Text] [Related]
5. Reply to Francesco Montorsi, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72.
Vickers AJ
Eur Urol; 2021 Dec; 80(6):e149. PubMed ID: 34600778
[No Abstract] [Full Text] [Related]
6. Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
Stavrinides V; Giganti F; Emberton M; Moore CM
Eur Urol; 2020 Oct; 78(4):e166. PubMed ID: 32712048
[No Abstract] [Full Text] [Related]
7. Reply to Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.005: Salvage Robotic Radical Prostatectomy for Recurrence After Focal Therapy-The Truth and Consequences.
Patel V; Bhat KRS; Moschovas MC; Noel J; Rogers T
Eur Urol Focus; 2022 Nov; 8(6):1864. PubMed ID: 35219650
[No Abstract] [Full Text] [Related]
8. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588-96.
Freedland SJ; Den RB
Eur Urol; 2016 Oct; 70(4):e110-e111. PubMed ID: 26992279
[No Abstract] [Full Text] [Related]
9. Reply to Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Elio Mazzone, Armando Stabile, and Alberto Briganti's Letter to the Editor re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al. Early Catheter Removal on Postoperative Day 2 After Robot-assisted Radical Prostatectomy: Updated Real-life Experience with the Aalst Technique. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.003.
Develtere D; Bravi CA; Mottrie A
Eur Urol Focus; 2022 Nov; 8(6):1862-1863. PubMed ID: 35315318
[No Abstract] [Full Text] [Related]
10. Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Moris L; Mottet N; Wiegel T;
Eur Urol; 2020 Nov; 78(5):e193-e194. PubMed ID: 32838999
[No Abstract] [Full Text] [Related]
11. Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
Knipper S; Maurer T
Eur Urol; 2021 May; 79(5):e134. PubMed ID: 33579574
[No Abstract] [Full Text] [Related]
12. Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007.
Zilli T; Ost P
Eur Urol Oncol; 2024 Feb; ():. PubMed ID: 38418267
[No Abstract] [Full Text] [Related]
13. Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15.
D'Andrea D; Soria F; Hurle R; Enikeev D; Kotov S; Régnier S; Xylinas E; Lusuardi L; Heidenreich A; Cai C; Frego N; Taraktin M; Ryabov M; Gontero P; Compérat E; Shariat SF;
Eur Urol Oncol; 2024 Jun; 7(3):639-640. PubMed ID: 37978025
[No Abstract] [Full Text] [Related]
14. Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
Meissner VH; Gschwend JE; Heck MM
Eur Urol; 2022 May; 81(5):e117. PubMed ID: 35131117
[No Abstract] [Full Text] [Related]
15. Reply to Francesco Montorsi and Giorgio Gandaglia's letter to the editor re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9.
Gakis G; Stief CG
Eur Urol; 2014 Dec; 66(6):e109-10. PubMed ID: 25204223
[No Abstract] [Full Text] [Related]
16. Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019.
Soria F; Gontero P
Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38278711
[No Abstract] [Full Text] [Related]
17. Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, Joāo A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients.
Patel V
Eur Urol; 2021 Feb; 79(2):e50-e51. PubMed ID: 33334623
[No Abstract] [Full Text] [Related]
18. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
Gandaglia G; Fossati N; Montorsi F; Briganti A
Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
[No Abstract] [Full Text] [Related]
19. Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, João A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients: Rio de Janeiro is Still Beautiful.
Ferreira Coelho R; Afonso de Carvalho P; Betoni Guglielmetti G; Dener Cordeiro M; Carlos Nahas W
Eur Urol; 2021 Feb; 79(2):e47-e49. PubMed ID: 33162248
[No Abstract] [Full Text] [Related]
20. Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80.
Schilham MGM; Rijpkema M; Scheenen T; Hermsen R; Barentsz JO; Sedelaar JPM; Kusters-Vandevelde H; Kerkmeijer LGW; Somford DM; Gotthardt M
Eur Urol; 2023 May; 83(5):e133-e134. PubMed ID: 36781337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
